|
|
|
Volumn 2, Issue 5, 2004, Pages 284-289
|
|
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CYTOCHROME P450 2D6;
DEXAMETHASONE;
DOLASETRON MESILATE;
INDOLE DERIVATIVE;
ISOQUINOLINE DERIVATIVE;
ONDANSETRON;
PALONOSETRON;
QUINOLIZINE DERIVATIVE;
QUINUCLIDINE DERIVATIVE;
SEROTONIN 3 RECEPTOR;
SEROTONIN ANTAGONIST;
ACUTE DISEASE;
ADULT;
AGED;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ANTAGONISM;
FEMALE;
HALF LIFE TIME;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
NAUSEA;
NEOPLASM;
PROTEIN BINDING;
REVIEW;
VOMITING;
ACUTE DISEASE;
ADULT;
AGED;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
CYTOCHROME P-450 CYP2D6;
DEXAMETHASONE;
FEMALE;
HALF-LIFE;
HUMANS;
INDOLES;
ISOQUINOLINES;
MALE;
MIDDLE AGED;
NAUSEA;
NEOPLASMS;
ONDANSETRON;
PROTEIN BINDING;
QUINOLIZINES;
QUINUCLIDINES;
RECEPTORS, SEROTONIN, 5-HT3;
SEROTONIN ANTAGONISTS;
VOMITING;
|
|
EID: 34249797673
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (27)
|
